Increases in β-amyloid protein in the hippocampus caused by diabetic metabolic disorder are blocked by minocycline through inhibition of NF-κB pathway activation. [electronic resource]
Producer: 20110916Description: 381-91 p. digitalISSN:- 2299-5684
- Amyloid beta-Peptides -- drug effects
- Animals
- Behavior, Animal -- drug effects
- Diabetes Mellitus, Experimental -- drug therapy
- Dietary Fats
- Down-Regulation -- drug effects
- Hippocampus -- drug effects
- Learning Disabilities -- drug therapy
- Male
- Memory Disorders -- drug therapy
- Minocycline -- pharmacology
- NF-kappa B -- antagonists & inhibitors
- Neuroprotective Agents -- pharmacology
- Rats
- Rats, Wistar
- Streptozocin
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.